REITWAVE.COM Institutional Equity Tear Sheet Generator
Download Vector PDF Export Model (CSV)
REITWAVE.COM | INSTITUTIONAL REAL ESTATE RESEARCH
AS OF: OCTOBER 24, 2026  |  10Y TREASURY: 4.99%  |  SIC 6798

NATIONAL HEALTH INVESTORS INC ($NHI)

Sector: Healthcare Facilities  •  Exchange / CIK: NYSE / 0000877860  •  Properties: 150 Assets
Trading at a 8.3% discount to NAV
Safety Score: 72/100 (Moderate Risk)  |  Credit: BBB

Live Share Price

$67.06
52W Range: $63.51 - $91.38

Valuation Multiples

14.0x P/AFFO
P/FFO: 13.0x  |  FFO/sh: $5.17

Net Asset Value (NAV)

$73.10
Prem/Disc: -8.3%  |  Cap: 6.54%

Dividend Cash Flow

5.58% Yield
$3.74/yr (Quarterly)  |  Payout: 78.1%
Balance Sheet & Debt Maturity Sentry
Net Debt to EBITDAre stands at 5.6x. Portfolio leased occupancy is 90.0% with a weighted average lease term (WALT) of 6.5 years. Senior credit rating of BBB provides institutional capital markets access for debt refinancing.
Recent Dividend Payment History (Last 6 Declarations)
Ex-Dividend Date Record / Pay Date Cash Distribution Status / Corporate Action
2026-09-30 2026-10-15 $0.9350 Regular Distribution
Representative Commercial Asset Concentrations (From SEC Form 10-K Item 2)
Commercial Asset / Property Name Location Rentable Sq Ft Occupancy Implied Asset Valuation
NATIONAL HEALTH INVESTORS INC Flagship Commercial Portfolio United States Nationwide 18,750,000 sq ft (implied) 90.0% $10,965,000,000
Quantitative Risk & Benchmark Performance (QuantStats • VNQ)
Empirical 252-day trading window compared to Vanguard Real Estate ETF (VNQ) benchmark
METHODOLOGY: QUANTSTATS / CAPM
Beta vs VNQ
0.81
Defensive (Low Sensitivity)
Annualized Alpha (α)
-7.76%
Trailing VNQ
Sharpe Ratio (vs VNQ)
-0.35 vs 0.04
-0.39 Spread
Max Drawdown (1-Yr)
-27.1% vs -11.4%
-15.7% vs VNQ
NHI vs VNQ QuantStats Performance & Underwater Drawdown
Quantitative Risk & Return Metric NHI VNQ (Benchmark) Institutional Delta / Spread
Beta (β) vs VNQ
Covariance sensitivity to US REIT market
 0.81 1.00 -0.19 (Defensive (Low Sensitivity))
Annualized Alpha (α)
Excess CAPM risk-adjusted performance
 -7.76% 0.00% (Baseline) Trailing VNQ
Sharpe Ratio (Rf = 4.5%)
Annualized excess return per unit of volatility
 -0.35 0.04 -0.39
Sortino Ratio
Downside semi-variance risk-adjusted return
 -0.33 0.03 -0.36
Annualized Volatility (σ)
Standard deviation of daily price returns × √252
 23.7% 13.9% +9.8% (Higher Volatility)
Maximum Drawdown (1-Year)
Peak-to-trough capital decline over trailing 12M
 -27.1% -11.4% -15.7% vs VNQ
1-Year Trailing Return (CAGR)
Compounded annual growth rate
 -6.3% 4.1% -10.4% Spread
R-Squared (R²) & Correlation
Statistical correlation coefficient against VNQ
 R² 0.23 Corr: 0.48 23% variance explained by VNQ
Trading Session Win Rate
Percentage of positive daily closing sessions
 50.4% 51.6% -1.2% vs Benchmark
QuantStats Analytical Synthesis: NHI displays a Beta of 0.81 relative to VNQ with 0.23 R² correlation. Annualized volatility is 23.7% (9.8% higher than VNQ at 13.9%). Trailing 12-month Alpha stands at -7.76% (Trailing VNQ) with a Sharpe ratio of -0.35 against 0.04 for VNQ, and a maximum drawdown of -27.1%.
SEC CIK: 0000877860  |  Principal Executive Officer: Executive Leadership / NATIONAL Corp  |  Total PEO Compensation: Reported in DEF 14A (N/A)
Official SEC Accession: 0000877860-26-000001
CONFIDENTIAL INSTITUTIONAL TEAR SHEET • REITWAVE.COM (v1.0.0) • Data Sources: SEC EDGAR Form 10-K / DEF 14A, PR Newswire, Bloomberg/CBRE Comps. For institutional and accredited investor due diligence. Not a solicitation or investment recommendation.